Silva Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
For the nine months, sales was BDT 582.5 million compared to BDT 615.86 million a year ago. Net income was BDT 53.39 million compared to BDT 98.99 million a year ago. Basic earnings per share from continuing operations was BDT 0.39 compared to BDT 0.73 a year ago.